The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Will The Market Size Of The Spatial Genomics And Transcriptomics Market Evolve From 2026 To 2030?
The market size for spatial genomics and transcriptomics has seen rapid expansion recently. This market is anticipated to expand from $1.7 billion in 2025 to reach $1.91 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.4%. Factors contributing to its historical growth include advances in genomics, expansion in transcriptomics research, the discovery of oncology biomarkers, a reduction in sequencing costs, and enhanced research funding.
The spatial genomics and transcriptomics market is projected to experience substantial expansion in the coming years. By 2030, its valuation is anticipated to reach $3.02 billion, demonstrating a compound annual growth rate (CAGR) of 12.1%. This anticipated increase over the forecast period is primarily driven by factors such as the demand for personalized oncology, advancements in drug discovery applications, the expansion of single-cell analysis, growth in computational biology, and a heightened focus on clinical translation. Key trends expected during this period involve the development of spatial mapping technologies, the incorporation of AI analytics, a surge in oncology research adoption, an increase in academic partnerships, and enhanced investment from pharmaceutical companies.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24405&type=smp
What Key Drivers Are Influencing The Growth Of The Spatial Genomics And Transcriptomics Market?
The expanding acceptance of personalized medicine is anticipated to fuel the expansion of the spatial genomics and transcriptomics market in the future. Personalized medicine defines a medical strategy that customizes treatment regimens for individual patients, considering their genetic profile, way of life, and environmental influences, aiming to boost treatment efficacy and lessen adverse reactions. The rising need for personalized medicine stems from progress in genetic studies, facilitating more exact therapies specifically designed for an individual’s distinct genetic composition, which results in improved patient outcomes. Spatial genomics and transcriptomics facilitate personalized medicine by uncovering the exact positioning and function of genes within biological tissues, thereby enabling targeted, customized therapeutic approaches tailored to a patient’s unique molecular makeup. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA cleared 16 novel personalized treatments for individuals with rare conditions in 2023, representing a notable rise from the six approvals documented in 2022. Consequently, the growing embrace of personalized medicine is propelling the development of the spatial genomics and transcriptomics market.
Which Segment Areas Are Covered In The Spatial Genomics And Transcriptomics Market Analysis?
The spatial genomics and transcriptomics market covered in this report is segmented –
1) By Product: Instruments, Consumables, Software
2) By Technology: Spatial Transcriptomics, Sequencing-Based Methods, Immunohistochemistry (IHC), Microscopy-Based RNA Imaging Techniques, Spatial Genomics
3) By Application: Diagnostics, Translation Research, Drug Discovery And Development, Single Cell Analysis, Cell Biology, Other Applications
4) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Academic And Research Institutes
Subsegments:
1) By Instruments: Sequencing Platforms, Imaging Systems, Fluorescence Microscopes, Slide Scanners, Flow Cytometers
2) By Consumables: Reagents And Kits, Slides And Coverslips, Probes And Tags, Sample Preparation Consumables
3) By Software: Data Analysis And Visualization Tools, Image Analysis Software, Workflow Management Software, Cloud-Based Analytics Platforms
Which Upcoming Trends Are Expected To Influence The Spatial Genomics And Transcriptomics Market?
Leading firms in the spatial genomics and transcriptomics market are concentrating on creating novel solutions, including spatial transcriptomics technologies, to deepen insights into gene expression within tissue architecture. These spatial transcriptomics technologies are sophisticated methods designed to map gene expression across tissue samples, retaining their spatial context, which allows investigators to examine the precise location and arrangement of RNA molecules in tissues. As an illustration, in February 2025, Illumina Inc., a US-based biotechnology company, unveiled a groundbreaking spatial transcriptomics technology that markedly improves the capacity to map and analyze gene expression in intricate tissues at cellular resolution. This technology boasts a capture area nine times larger and four times higher resolution compared to current methodologies, facilitating unbiased, whole-transcriptome profiling with high sensitivity. Fully compatible with Illumina’s NextSeq and NovaSeq sequencers and seamlessly integrated into the Illumina Connected Multiomics platform, this innovation supports comprehensive multiomic data analysis.
Which Global Companies Are Actively Competing In The Spatial Genomics And Transcriptomics Market?
Major companies operating in the spatial genomics and transcriptomics market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Bio-Techne Corporation, 10x Genomics Inc., Standard BioTools Inc., Akoya Biosciences Inc., Seven Bridges Genomics, Vizgen Inc., Lunaphore Technologies SA., Parse Biosciences, Indica Labs Inc., Resolve Biosciences GmbH., RareCyte Inc., Ionpath Inc., Dovetail Genomics, S2 Genomics Inc., BioSpyder Technologies Inc.
Read the full spatial genomics and transcriptomics market report here:
Which Region Is Expected To Register The Fastest Growth In The Spatial Genomics And Transcriptomics Market?
North America was the largest region in the spatial genomics and transcriptomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the spatial genomics and transcriptomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Spatial Genomics And Transcriptomics Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=24405&type=smp
Browse Through More Reports Similar to the Global Spatial Genomics And Transcriptomics Market 2026, By The Business Research Company
Rna Analysis Transcriptomics Global Market Report
https://www.thebusinessresearchcompany.com/report/rna-analysis-transcriptomics-global-market-report
Plant Genomics Global Market Report
https://www.thebusinessresearchcompany.com/report/plant-genomics-global-market-report
Optical Genome Mapping Global Market Report
https://www.thebusinessresearchcompany.com/report/optical-genome-mapping-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model